CLSN

Stock ticker:
NASDAQ

61 days until earnings call

Intraday data for

Jan 27, closing price

Price

$0.42

Change

$0.00 (0.00%)

Capitalization

$36.5m

CLSN Price Prediction, Celsion Corp AI Recommendations

a company which engages in the provision of oncology drug development services

Industry @Biotechnology

View Trends for CLSN(TRY FOR FREE)

Paper trades

Copy to...

Stock ticker: NASDAQ

CLSN

AS OF

Jan 27, closing price

Price

$0.42

Change

$0.00 (0.00%)

Capitalization

$36.5m

61 days until earnings call

CLSN Price Prediction, Celsion Corp AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

a company which engages in the provision of oncology drug development services

Industry @Biotechnology

View Trends for CLSN(TRY FOR FREE)

Paper trades

Copy to...

A.I.dvisor published

CLSN Commentaries and news forecasts

3:00 PM EST Jan 27

CLSN (Celsion Corp): Weekly Commentary

Please wait a moment while the chart loads...

An error occurred while loading prices!

These past five trading days, the stock lost -7.45% with an average daily volume of 61042 shares traded. The stock tracked a drawdown of -22.2% for this period.

Please wait a moment while the chart loads...

An error occurred while loading prices!

View to see Real Time Patterns for CLSN (TRY FOR FREE)

AI Screener Basics

Expand

AI Screener FA & TA

Expand

Forecasts, Signals and Predictions about CLSN (Celsion Corp)

Technical Analysis	# Of Indicators	Avg. Odds
Bullish trend Bullish trend
Bearish trend Bearish trend
Bearish trend
Bullish trend

Fundamental Analysis	(1 - best, 100 - worst)

+321%

Swing Trader Crypto (ALGO, IOST, LINK, QTUM, NEO)

384 days traded

+325%

Swing Trader Crypto (TRX, SXP, RLC, XMR, ZEC)

390 days traded

+347%

Swing Trader Crypto (ETH, LTC, BCH, ADA, BNB)

390 days traded

A.I.dvisor published

a Summary for CLSN with price predictions.

4:00 PM EST Jan 27

CLSN in upward trend: price may ascend as a result of having broken its lower Bollinger Band on January 13, 2022

CLSN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where CLSN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Current price $0.42 crossed the resistance line at $1.55 and is trading between $1.55 resistance and $-5.73 support lines. Throughout the month of 12/27/21 - 01/27/22, the price experienced a -29% Downtrend. During the week of 01/20/22 - 01/27/22, the stock fell -4%.

A.I.dvisor published

Celsion Corp Earnings Data

CLSN is expected to report earnings to -5 cents per share on March 30

Q4'21

Est.

$-0.06

Q3'21

Beat

by $0.03

Q2'21

Beat

by $0.02

Q1'21

Missed

by $0.03

Q4'20

Beat

by $0.08

The last earnings report on November 15 showed earnings per share of -5 cents, beating the estimate of -8 cents. With 390.39K shares outstanding, the current market capitalization sits at 36.54M.

Industry	Medical Specialties
Address	997 Lenox Drive, Lawrenceville, NJ, 08648
Phone	+1 609 896-9100
Employees	27
Web	https://www.celsion.com

Capitalization Capitalization	36.5M
P/E Ratio P/E Ratio	N/A
Risk (Beta) Risk (Beta)	1.90
Dividend Yield Dividend Yield	N/A
Total Cash Total Cash	58.4M
Total Cash/Share Total Cash/Share	0.67
Total Debt Total Debt	6.696M
Total Debt/Equity Total Debt/Equity	12.33
Projected Growth (PEG Ratio) Projected Growth (PEG Ratio)	N/A
Revenue/Share (as % of the share price) Revenue/Share (as % of the share price)	0%
Revenue Revenue	500K
ROE ROE	N/A
Book Value Book Value	64.1M
P/B Ratio P/B Ratio	0.61
Cash Flow Cash Flow	N/A
Earnings Earnings	-0.450
Average Daily Volume YTD Average Daily Volume YTD	N/A
Common Shares Outstanding - Security Level Common Shares Outstanding - Security Level	866K
Current Ratio Current Ratio	11.21
Current Revenue Per Employee Current Revenue Per Employee	4,629.63
Dividends Per Share - Security Dividends Per Share - Security	N/A
EBITDA EBITDA	-22,329,424
Float Float	N/A
Float - Current Float - Current	N/A
Gross Income Margin Gross Income Margin	100.00
Revenue To Assets Revenue To Assets	-34.26
Shares Held By Institutions Shares Held By Institutions	11.1M
Shares Outstanding - Current Shares Outstanding - Current	N/A
Total Liabilities Total Liabilities	19M
Total Volume MTD Total Volume MTD	N/A
Value	Fair
Gain YTD	-22.574

Group	Domestic Stock Funds
Category	Biotechnology
Total Expense Ratio Total Expense Ratio
Min. Initial Investment Min. Initial Investment	0.00 USD
Fund Existence Fund Existence	a few seconds ago
Turnover Turnover
Front Load Front Load
Net Assets Net Assets	0.00 USD
Manager Tenure Manager Tenure

Group	Domestic Stock Funds
Category	Biotechnology
Capitalization Capitalization	36.54m USD
P/E Ratio P/E Ratio	N/A
Total Cash Total Cash	58.36m USD
Projected Growth Projected Growth	N/A
Total Debt Total Debt	6.70m USD
Revenue Revenue	500.00k USD
Risk (Beta) Risk (Beta)	1.90
Dividend Yield Dividend Yield	N/A
Total Cash/Share Total Cash/Share	0.67
Total Debt/Equity Total Debt/Equity	12.33
Revenue/Share Revenue/Share	0.00USD	as % of share price

Group	Domestic Stock Funds
Category	Biotechnology
Net Assets Net Assets	0.00 USD
Fund Existence Fund Existence	a few seconds ago
Turnover Turnover
Capitalization Capitalization
Yield Yield
Total Expense Ratio Total Expense Ratio
Investment Style Investment Style
Risk (Beta) Risk (Beta)

Group	Domestic Stock Funds
Category	Biotechnology
Market Capitalization	0.00 USD
Volume	0.00 USD

A.I.dvisor

published a Pattern (end of day)

A.I.dvisor tells us that CLSN and VSS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLSN and VSS's prices will move in lockstep.

TICKER / NAME	CORRELATION TO CLSN	1D PRICE CHANGE %
CLSN	100%	0.00%
VSS - CLSN	28% Poorly correlated	-1.00%
VEA - CLSN	24% Poorly correlated	-0.66%
VGK - CLSN	22% Poorly correlated	-0.22%

Interesting Tickers

STOCK / NAME	PRICE $	CHG $	CHG %
		1 Day
SIRI	6.13	0.15	+2.51%
Sirius XM Holdings
WSFS	51.05	-1.62	-3.08%
WSFS Financial
STTK	6.06	-0.37	-5.75%
Shattuck Labs
ORLA	3.43	-0.21	-5.77%
Orla Mining
CLIR	1.04	-0.08	-7.14%
ClearSign Technologies

Related Tickers to CLSN

STOCK / NAME	PRICE $	CHG $	CHG %
		1 Day
ABIO	1.81	-0.05	-2.69%
ARCA biopharma
NBY	0.29	-0.01	-3.33%
NovaBay Pharmaceuticals
AIKI	0.48	-0.03	-5.88%
AIkido Pharma
ZSAN	0.43	-0.03	-6.52%
Zosano Pharma
SYN	0.23	-0.02	-8.00%
Synthetic Biologics

A.I.dvisor indicates that over the last year, CLSN has been loosely correlated with AIKI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CLSN jumps, then AIKI could also see price increases.

TICKER / NAME	CORRELATION TO CLSN	1D PRICE CHANGE %
CLSN	100%	0.00%
AIKI - CLSN	48% Loosely correlated	-5.88%
SYN - CLSN	44% Loosely correlated	-8.00%
ZSAN - CLSN	43% Loosely correlated	-6.52%
NBY - CLSN	41% Loosely correlated	-3.33%
ABIO - CLSN	40% Loosely correlated	-2.69%

CLSN Price Prediction, Celsion Corp AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

CLSN (Celsion Corp): Weekly Commentary

Forecasts, Signals and Predictions about CLSN (Celsion Corp)

CLSN in upward trend: price may ascend as a result of having broken its lower Bollinger Band on January 13, 2022

Technical Analysis, Outlook, Fundamental Analysis READ MORE...

CLSN is expected to report earnings to -5 cents per share on March 30

General Information

Select Stock attributes to show

1 Day

1 Day

CLSN (Celsion Corp): Weekly Commentary

Forecasts, Signals and Predictions about CLSN (Celsion Corp)

Technical Analysis, Outlook, Fundamental Analysis READ MORE...

General Information

Select Stock attributes to show

CLSN: pattern detected on

1 Day

1 Day